JP2025515096A5 - - Google Patents

Info

Publication number
JP2025515096A5
JP2025515096A5 JP2024564931A JP2024564931A JP2025515096A5 JP 2025515096 A5 JP2025515096 A5 JP 2025515096A5 JP 2024564931 A JP2024564931 A JP 2024564931A JP 2024564931 A JP2024564931 A JP 2024564931A JP 2025515096 A5 JP2025515096 A5 JP 2025515096A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
halogen
halogenated
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515096A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066533 external-priority patent/WO2023215775A1/en
Publication of JP2025515096A publication Critical patent/JP2025515096A/ja
Publication of JP2025515096A5 publication Critical patent/JP2025515096A5/ja
Pending legal-status Critical Current

Links

JP2024564931A 2022-05-04 2023-05-03 Trpa1阻害剤としてのピリドン化合物 Pending JP2025515096A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263338181P 2022-05-04 2022-05-04
US63/338,181 2022-05-04
PCT/US2023/066533 WO2023215775A1 (en) 2022-05-04 2023-05-03 Pyridone compounds as trpa1 inhibitors

Publications (2)

Publication Number Publication Date
JP2025515096A JP2025515096A (ja) 2025-05-13
JP2025515096A5 true JP2025515096A5 (cg-RX-API-DMAC7.html) 2026-05-11

Family

ID=88647177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564931A Pending JP2025515096A (ja) 2022-05-04 2023-05-03 Trpa1阻害剤としてのピリドン化合物

Country Status (8)

Country Link
US (1) US20250270198A1 (cg-RX-API-DMAC7.html)
EP (1) EP4519250A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025515096A (cg-RX-API-DMAC7.html)
CN (1) CN119451948A (cg-RX-API-DMAC7.html)
AR (1) AR129212A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250397A1 (cg-RX-API-DMAC7.html)
TW (1) TW202400148A (cg-RX-API-DMAC7.html)
WO (1) WO2023215775A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025167992A1 (zh) * 2024-02-08 2025-08-14 宜昌人福药业有限责任公司 一种非选择性阳离子通道trpa1拮抗剂及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017060488A1 (en) * 2015-10-09 2017-04-13 Almirall, S.A. New trpa1 antagonists
WO2022056042A1 (en) * 2020-09-09 2022-03-17 University Of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy
CA3211048A1 (en) * 2021-04-14 2022-10-20 Boehringer Ingelheim International Gmbh 3h,4h,5h,6h,7h-pyrimido[4,5-b][1,4]oxazine-4,6-dione derivatives as trpa1 inhibitors
US20250136587A1 (en) * 2022-02-03 2025-05-01 D. E. Shaw Research, Llc N3-substituted uracil compounds as trpa1 inhibitors

Similar Documents

Publication Publication Date Title
JP2025506372A5 (cg-RX-API-DMAC7.html)
US6218397B1 (en) Pyrazolopyrimidines as CRF antagonists
JP2025506422A5 (cg-RX-API-DMAC7.html)
DE69711430T2 (de) PYRROLO[3,4-d]PYRIMIDINON-DERIVATE UND IHRE VERWENDUNG ALS IMMUNOSUPPRESSOREN
WO1995028387A1 (en) Benzamide compound and medicinal use thereof
RU2007146798A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2010540508A5 (cg-RX-API-DMAC7.html)
CA2665476A1 (en) Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
US5063227A (en) Quinazoline-substituted pyridazinone derivatives having cardiotonic activity
SK83594A3 (en) Imidazole derivatives, method of their preparation, their use for production of pharmaceutical compositions with their contents
JP2013526494A5 (cg-RX-API-DMAC7.html)
SK135699A3 (en) Pyrazolo[3,4-d]pyrimidinedione compounds, preparation method thereof, pharmaceutical composition containing them and their use
KR102428882B1 (ko) 카이네이즈 저해제로서의 피롤로트리아진 유도체
IL235097A (en) History of insulin-2 and as protein kinase inhibitors
SK278310B6 (en) Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof
JPH06228108A (ja) フタラジノン誘導体
DE69115744T2 (de) Konjugate von Difluoroglutaminsäure mit Fölaten und Antifölaten für die Behandlung von neoplastischen Krankheiten
JP7618642B2 (ja) インターロイキンの調節におけるプロドラッグ
EP2632916B1 (en) Novel anti-cancer agents
DE69226703T2 (de) Imidazo (4,5-c)pyridinderivate als paf antagonisten
US4711883A (en) Substituted 3-(4-phenyl-1-piperazinyl)alkylquinazolin-2,4-(1H,3H) diones, methods of preparation, compositions and method of use
US7750049B2 (en) O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists
US8202899B2 (en) Pyrazole urea derivatives used as kinase inhibitors
JPH0196180A (ja) ベンゾイミダゾール化合物、その製造法およびこれらの化合物を含有する心機能不全治療用組成物
KR20240007619A (ko) 포스포리파제 d 억제제로서의 신규 화합물 및 이의용도